Thought this would be of interest, especially in this community, where a certain wariness about the COVID-19 vax (born, no doubt, out of various experiences with the medical community) has kept some of the members here on the sidelines, waiting for more info to surface.
Probably even more interesting


to anyone who's already had the vaccine, and chose the one-and-done J&J version ...
BREAKING NEWS: FDA is set to announce new warning on J&J vaccine after 100 reports of it being linked to rare autoimmune disease Guillain-Barré syndrome
https://www.dailymail.co.uk/health/...notification&ci=303097&si=35219563&ai=9781291
Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older.
With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.
The warning is yet another setback for J&J's vaccine, which has plagued by pauses, ingredient mix-ups and doses needing to be thrown out.
Probably even more interesting
BREAKING NEWS: FDA is set to announce new warning on J&J vaccine after 100 reports of it being linked to rare autoimmune disease Guillain-Barré syndrome
https://www.dailymail.co.uk/health/...notification&ci=303097&si=35219563&ai=9781291
- The FDA is planning to release a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease
- Officials say there have been 100 reports of patients developing Guillain-Barré syndrome, a rare disorder that temporarily paralyzes parts of the body
- Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older
- Guillain-Barré is very rare after vaccination, occurring in just 0.000781% of patients who have received J&J's one-dose shot
- The warning presents another setback for the company, which has been plagued by challenges including a pause due to rare blood clots and ingredient mix-ups
Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older.
With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.
The warning is yet another setback for J&J's vaccine, which has plagued by pauses, ingredient mix-ups and doses needing to be thrown out.